InMode Ltd. (NASDAQ:INMD) Q3 2022 Results Conference Call October 27, 2022 8:30 AM ET

Company Participants

Miri Segal - Investor Relations, MS-IR LLC

Moshe Mizrahy - Chairman and Chief Executive Officer

Michael Kreindel - Chief Technology Officer & Director

Yair Malca - Chief Financial Officer

Shakil Lakhani - President, North America

Spero Theodorou - Chief Medical Officer

Rafael Lickerman - VP of Finance

Conference Call Participants

Kyle Rose - Canaccord Genuity

Matt Taylor - Jefferies

Jeff Johnson - Baird

Joseph Conway - Needham

Operator

Good day and welcome to the InMode Third Quarter 2022 Earnings Results Conference Call. All participants will be in a listen-only mode. [Operator instructions] Please note this event is being recorded.

I would now like to turn the conference over to Miri Segal, CEO of MS-IR. Please go ahead.

Miri Segal

Thank you, operator, and everyone for joining us today. Before we begin, I'd like to remind our listeners that certain information provided on this call may contain forward-looking statements, and that the safe harbor statement outlined in today's earnings release also pertains to this call. If you have not received a copy of the release, please go to the Investor Relations section of the company's website.

Changes in business, competitive, technological, regulatory and other factors could cause actual results to differ materially from those expressed by the forward looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of our forward-looking statements and assume no obligation to update them except as required by law.

With that, I'd like to pass the call over to Moshe Mizrahy, Chairman and CEO. Moshe, please go ahead.

Moshe Mizrahy

Thank you, Miri, and to everyone joining us for Q3 2022 earnings calls. With me today are Dr. Michael Kreindel, our Co-founder and Chief Technology Officer; Yair Malca our CFO; Shakil Lakhani, our President in North America; Dr. Spero Theodorou, our Chief Medical Officer; and Rafael Lickerman, our VP of Finance. Following our prepared remark, we will all be available for Q&A session.

We are pleased to report another record quarter with revenue of $121.2 million, an increase of 29% compared to the same period last year. Additionally, we are happy to be back to gross margin of 85%. Despite our expectation that Q3 should represent somewhat slow quarter demand for our innovative platforms remain strong around the world in Q3, and we expect this momentum to continue into next year. Although physician and patient we tend to pre-COVID travel levels, people still visited clinics for treatment with our platform.